Carregant...
Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
BACKGROUND: The proteasome inhibitor bortezomib can inhibit activation of the transcription factor NF-κB, a mechanism implicated in its anti-neoplastic effects observed in mantle cell lymphoma (MCL). However, NF-κB can be activated through many distinct mechanisms, including proteasome independent p...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2408930/ https://ncbi.nlm.nih.gov/pubmed/18489772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-7-40 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|